Comparing the current results to its competitors, Cencora Inc reported Revenue increase in the 2 quarter 2026 by 3.85 % year on year. The revenue growth was below Cencora Inc 's competitors' average revenue growth of 6.72 %, achieved in the same quarter.
Cencora Inc 's Comment on Competition and Industry Peers
The pharmaceutical distribution industry is characterized by intense competition from pharmaceutical distributors, manufacturers selling directly to customers, chain drugstores with in-house warehousing, specialty distributors, and packaging and healthcare technology companies. The healthcare sector is undergoing consolidation and forming strategic alliances among pharmaceutical manufacturers, retail pharmacies, healthcare providers, and health insurers, potentially increasing competitive pressures. The company faces risks associated with customer creditworthiness, pricing structures, manufacturer distribution relationships, and intellectual property protection. Additionally, external factors such as public health issues, natural disasters, government policy changes, and political events may adversely affect the company.
Overall company revenue, grew less, than total company revenues, at 3.85 % and company approximately market share, declined to 31.97 %. << More on COR Market Share.
*Market share is calculated based on total revenue.
November 6, 2024
Cencora, Inc. (NYSE: COR), a renowned player in the healthcare services sector, has recently announced its definitive agreement to acquire Retina Consultants of America (RCA). RCA, a leading management services organization (MSO) specializing in retina care, stands poised to enhance Cencora s landscape with its robust network and specialized expertise. This strategic move underscores Cencora s commitment to expanding its presence in high-growth segments of the healthcare market, particularly within specialty care.The acquisition aligns with Cencora s broader strategy of solidifying its relationships with community healthcare providers while maintaining its leadership in specialty services. Bob Mauch, Preside...
Amneal Pharmaceuticals Inc operates as a fully integrated pharmaceutical company, primarily focused on the development, manufacturing, and distribution of generic and specialty pharmaceutical products. Their business model revolves around identifying market opportunities, conducting research to develop cost-effective formulations, and leveraging their expansive manufacturing capabilities to produce and distribute a wide range of pharmaceuticals to customers globally. Additionally, they aim to provide high-quality products at competitive prices while continuously investing in research and development to expand their product portfolio.
McKesson Corporations business model centers on healthcare distribution and technology solutions, supplying pharmaceuticals, medical supplies, and business services to pharmacies, hospitals, and healthcare providers. They emphasize efficiency and innovation in healthcare delivery.
Iron Mountain Incs business model focuses on delivering comprehensive storage and information management solutions to businesses across diverse industries. Their offerings include secure storage for physical documents and digital assets, as well as a range of services such as data management, document imaging, and secure destruction. This strategy enables organizations to protect sensitive information while ensuring regulatory compliance and operational efficiency.
Equinix Incs business model focuses on offering a vast network of international data centers that enable secure, reliable interconnection for enterprises, cloud providers, and network service providers. By facilitating seamless data exchange and providing essential infrastructure services, Equinix supports digital transformation and the increasing demand for connectivity in an increasingly data-driven world.
Digital Realty Trust Inc operates a business model centered on owning, acquiring, and managing a global portfolio of data centers. The company offers reliable physical infrastructure and related services, supporting organizations in the technology sector to effectively store and manage their essential IT systems and network operations.
Sources:
Cencora Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cencora Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
